IP Library Granted Patent US 12,193,782
Granted Patent B2
US 12,193,782 · App. 17/735,442 · Granted Jan 14, 2025

Ambulatory medical device and method for communication between medical devices

Inventors: Matthias Essenpreis (Burgdorf, CH); Ulrich Haueter (Grosshoechstetten, CH); Nicole Bernini (Ersigen, CH); Sybille Kaeser (Zollikofen, CH); Sebastiaan La Bastide (Muri bei Bern, CH); Gunnar Meyer Olden (Burgdorf, CH); Michael Schoemaker (Mannheim, DE); Kelly Heaton (Ersigen, CH); Joel Jeckelmann (Villars-sur-Glane, CH)
Assignee: ROCHE DIABETES CARE, INC.
A61B5/0002A61M5/14244A61B5/14532A61M5/14276A61M2205/3523A61M2205/3569A61M2205/3592A61M2230/201
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,193,782
App. No.
17/735,442
Granted
Jan 14, 2025
Kind
B2
Abstract

An ambulatory medical device and a method of communication between medical devices are disclosed. In one embodiment, the medical device includes a module for communication with at least a second medical device wherein the module for communication is adapted to be activated by a value of a physiological parameter of an animal. In one embodiment, the method of the present invention involves a first medical device and at least a second medical device wherein the communication between said medical devices is activated by a value of a physiological parameter of an animal.

Claims (27)

1. A system of medical devices comprising:

a first medical device selected from the group consisting of a remote control, a PDA, an analyte measuring device, a glucose measuring device, a hand-held glucose meter, a strip based or strip type glucose meter, a medical sensory device, a continuous glucose sensor, a therapeutic device, an insulin pump, a diagnostic medical device, a glucose meter, a device for injecting, infusing, delivering, dispensing or administering substances, and an ambulatory medical device,

the first medical device being configured to generate a first value based upon a physiological parameter representative of a parameter of an animal selected from the group consisting of: an analyte concentration, conductivity, a vital sign, a heart rate, a breath rate, temperature, movement, air-borne sound, structure-borne sound, an electrocardiogram, and a blood glucose concentration of an animal; and

a second medical device capable of communicating with the first medical device, the second medical device being selected from the group consisting of an extra corporal infusion pump, an implantable infusion pump, a pacesetter, an analyte sensor, a vital sign sensor, a continuous analyte sensor, a continuous vital sign sensor, and a continuous glucose sensor,

the first medical device including a communication module establishing, in response to generating the first value, a wireless communication link enabling communication between the first medical device and the second medical device,

the first medical device obtaining a second obtained value of a physiological parameter of the animal, a defined length of a time span for the communication link to be established being determined using the obtained second value of the physiological parameter of the animal, the communication module further being configured, following determination of the time span, to automatically activate for the defined time span from a deactivated state the wireless communication link,

the communication module being configured that after expiration of the defined time span the communication link between the first medical device and the second medical device is deactivated,

the first medical device being configured to send information to the second medical device during the defined time span, and the second medical device being configured to process the information received from the first medical device.

2. The system of claim 1 in which said continuous glucose sensor is configured to process the information during the defined time span.

3. The system of claim 1 in which the first value of a physiological parameter of the animal is the blood glucose value of the animal.

4. The system of claim 1 in which the information includes a command from the first medical device to at least partially control the second medical device.

5. The system of claim 4 in which the command from the first medical device is to automatically activate processing of the information by the second medical device based on transmitting the first value to the second medical device.

6. The system of claim 1 in which the second value is obtained by the first medical device from the second medical device during a previous communication between the first medical device and the second medical device.

7. The system of claim 1 in which the second value is obtained by data entry into the first medical device.

8. The system of claim 7 in which the second value is obtained by data entry of a glucose concentration determined by a test strip-based glucose meter.

9. A method of communicating between a first medical device and a second medical device, the first medical device including a communication module configured to activate from a deactivated state a wireless communication link enabling communication between the first medical device and the second medical device, comprising:

using the first medical device, generating a blood glucose value based upon a first value of a physiological parameter representative of the blood glucose concentration of the animal;

in response to the completion of the generation of the blood glucose value, automatically activating the communication link for a defined time span;

providing to the second medical device a second value of a physiological parameter representative of the glucose value of the animal;

using the provided second value of the physiological parameter, determining the defined time span for the wireless communication link to be established;

during the determined defined time span, transmitting information from the first medical device to the second medical device;

processing the information using the second medical device; and

upon expiration of the defined time span, automatically deactivating the communication link.

10. The method of claim 9 in which said processing comprises the second medical device processing the information during the defined time span.

11. The method of claim 9 in which the information includes a command from the first medical device to at least partially control the second medical device.

12. The method of claim 9 and further including sending data from the first medical device to the second medical device during the defined time span and processing the data using the second medical device.

13. The method of claim 12 in which said processing the data comprises the first medical device processing the data during the defined time span.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 29, 2022
From: ESSENPREIS, MATTHIAS; HAUETER, URLICH; BERNINI, NICOLE; FANKHAUSER, SYBILLE; OLDEN, GUNNAR MEYER; SCHOEMAKER, MICHAEL; HEATON, KELLY; JECKELMANN, JOEL; LA BASTIDE, SEBASTIAAN
To: DISETRONIC LICENSING AG
Reel/Frame 060350/0189 →
MERGER Recorded Jun 29, 2022
From: DISETRONIC LICENSING AG
To: ROCHE DIAGNOSTICS INTERNATIONAL AG
Reel/Frame 060350/0241 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 29, 2022
From: ROCHE DIAGNOSTICS INTERNATIONAL AG
To: ROCHE DIABETES CARE, INC.
Reel/Frame 060350/0275 →
Priority Claims (1)
EP 05002074 · Feb 2, 2005 · regional
Continuity (3)
Continuation 11832421 · Aug 1, 2007
Continuation PCTEP2006000663 · Jan 26, 2006
Related Publication 20220257117A1 · Aug 18, 2022
References Cited (37)
US 5507288A · Bocker et al. · 1996 [cited by applicant]
US 6289224B1 · Boxall · 2001 [cited by examiner]
US 6290646B1 · Cosentino et al. · 2001 [cited by applicant]
US 6295506B1 · Heinonen et al. · 2001 [cited by applicant]
US 6553244B2 · Lesho et al. · 2003 [cited by applicant]
US 6572543B1 · Christopherson et al. · 2003 [cited by applicant]
US 6641533B2 · Causey et al. · 2003 [cited by applicant]
US 6659948B2 · Lebel et al. · 2003 [cited by applicant]
US 7034677B2 · Steinthal et al. · 2006 [cited by applicant]
US 7276029B2 · Goode et al. · 2007 [cited by applicant]
US 7278983B2 · Ireland et al. · 2007 [cited by applicant]
US 20020010390A1 · Guice et al. · 2002 [cited by applicant]
US 20020016568A1 · Lebel · 2002 [cited by applicant]
US 20020049389A1 · Abreu · 2002 [cited by applicant]
US 20020129147A1 · Ogasawara · 2002 [cited by examiner]
US 20020143241A1 · Thorell · 2002 [cited by applicant]
US 20020151770A1 · Noll et al. · 2002 [cited by applicant]
US 20030041866A1 · Linberg · 2003 [cited by applicant]
US 20030065536A1 · Hansen et al. · 2003 [cited by applicant]
US 20030114898A1 · Von Arx et al. · 2003 [cited by applicant]
US 20030136418A1 · Behm · 2003 [cited by applicant]
US 20040077995A1 · Ferek-Petric · 2004 [cited by applicant]
US 20040102971A1 · Lipscher et al. · 2004 [cited by applicant]
US 20040116786A1 · Iijima et al. · 2004 [cited by applicant]
US 20040122702A1 · Sabol et al. · 2004 [cited by applicant]
US 20040167464A1 · Ireland et al. · 2004 [cited by applicant]
US 20040225338A1 · Lebel et al. · 2004 [cited by applicant]
US 20050080322A1 · Korman · 2005 [cited by applicant]
US 20050113717A1 · Matzinger et al. · 2005 [cited by applicant]
US 20050117066A1 · Kamijo · 2005 [cited by examiner]
US 20050182306A1 · Sloan · 2005 [cited by examiner]
US 20050192557A1 · Brauker et al. · 2005 [cited by applicant]
US 20050195930A1 · Spital et al. · 2005 [cited by applicant]
US 20070282177A1 · Pilz · 2007 [cited by applicant]
US 20070299324A1 · Rasch-Menges · 2007 [cited by examiner]
US 20100179409A1 · Kamath et al. · 2010 [cited by applicant]
EP 0098592 · 1984 [cited by applicant]